-
Ventas (VTR) PT Raised to $52 at RBC Capital, 'backdrop should drive solid earnings growth'
-
Ventas to Present at RBC Capital Markets Global Healthcare Conference
-
UPDATE: RBC Capital Upgrades Ventas (VTR) to Outperform
-
Ventas (VTR) PT Raised to $71 at RBC Capital
-
Ventas (VTR) PT Raised to $64 at RBC Capital
-
Ventas Announces Pricing of Senior Notes Offering
-
RBC Capital Downgrades Ventas (VTR) to Sector Perform
-
Ventas Replaces its Expired “At-the-Market” Equity Offering Program
-
Ventas (VTR) PT Lowered to $62 at RBC Capital
-
Notable Mergers and Acquisitions 7/6: (VTR) (NTK) (PKG) (MMSI)
-
RBC Capital Downgrades Ventas (VTR) to Outperform
-
Notable Analyst Rating Changes 10/6: (SPLK) (BDX) (COP) Upgraded; (TKMR) (MBLY) (NSM) Downgraded
-
Pre-Open Stock Movers 06/02: (NPSP) (PL) (BRCM) Higher; (PBYI) (MTZ) (CYTK) Lower (more...)
-
RBC Capital Upgrades Ventas (VTR) to Top Pick
-
Ventas (VTR) Establishes $750M At-The-Market Offering
-
Notable Mergers and Acquisitions of the Day 12/24: (EOG)/(CVX) (VTR)
-
RBC Capital Starts Ventas (VTR) at Outperform
-
Morning Movers 02/28: (MRX) (PSTR) (BDLI) (OSTK) Higher; (CPF) (KCP) (TLR) Lower

